Fujian, China

Shaojuan Wang

This inventor holds 1 USPTO granted patent. Top assignees: Xiamen University, Yang Sheng Tang Company Limited. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shaojuan Wang. Retrieved from https://idiyas.com/inventor/shaojuan-wang-2dixs3v8

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 1.0


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Shaojuan Wang: Innovator in Antiviral Treatments

Introduction

Shaojuan Wang is a notable inventor based in Fujian, China. He has made significant contributions to the field of antiviral treatments, particularly in the fight against hepatitis B. His innovative approach has led to the development of a patent that addresses a critical health issue.

Latest Patents

Shaojuan Wang holds a patent for the "Use of palovarotene in treatment against HBV virus." This patent focuses on the application of a specific compound represented by formula I in the treatment of hepatitis B virus (HBV). The invention aims to provide an effective antiviral treatment, showcasing Wang's commitment to advancing medical science.

Career Highlights

Throughout his career, Shaojuan Wang has worked with reputable organizations, including Yang Sheng Tang Company Limited and Xiamen University. His experience in these institutions has allowed him to collaborate with other experts in the field and contribute to groundbreaking research.

Collaborations

One of his notable collaborators is Jiali Cao. Their partnership has likely fostered innovative ideas and advancements in antiviral research.

Conclusion

Shaojuan Wang's work in developing antiviral treatments for hepatitis B demonstrates his dedication to improving public health. His patent and collaborations highlight his role as a significant contributor to medical innovation.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…